Efficacy and safety of twice-weekly and thrice-weekly dutasteride in men with androgenetic alopecia: A randomized, investigator-blind, active-controlled, parallel-group pilot study

Mendeley supplemental figures and table to accompany manuscript: Efficacy and safety of twice-weekly and thrice-weekly dutasteride in men with androgenetic alopecia: A randomized, investigator-blind, active-controlled, parallel-group pilot study.

Mendeley 补充图表，以辅助文稿：《每周两次和每周三次服用度他沙坦治疗雄激素性脱发男性患者的疗效与安全性：一项随机、研究者盲法、活性对照、平行组试点研究。'}